SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-20-008842
Filing Date
2020-07-31
Accepted
2020-07-31 09:02:06
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K argx-20200630x6k.htm 6-K 34141
2 EX-99.1 argx-20200630ex9910a44fe.htm EX-99.1 135791
3 EX-99.2 argx-20200630ex992ca70f9.htm EX-99.2 709752
4 GRAPHIC argx-20200630ex9910a44fe001.jpg GRAPHIC 3559
  Complete submission text file 0001558370-20-008842.txt   3368437

Data Files

Seq Description Document Type Size
5 EX-101.INS argx-20200630.xml EX-101.INS 665909
6 EX-101.SCH argx-20200630.xsd EX-101.SCH 43208
7 EX-101.CAL argx-20200630_cal.xml EX-101.CAL 50211
8 EX-101.DEF argx-20200630_def.xml EX-101.DEF 53885
9 EX-101.LAB argx-20200630_lab.xml EX-101.LAB 267925
10 EX-101.PRE argx-20200630_pre.xml EX-101.PRE 172167
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 201063876
SIC: 2836 Biological Products, (No Diagnostic Substances)